Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Aug 31;14(3):261-9.
doi: 10.9758/cpn.2016.14.3.261.

Efficacy and Tolerability of Paliperidone Extended-release in the Treatment of First-episode Psychosis: An Eight-week, Open-label, Multicenter Trial

Nam-In Kang  1 , Bon-Hoon Koo  2 , Sung-Wan Kim  3 , Jong-Hoon Kim  4 , Beomwoo Nam  5 , Bong-Ju Lee  6 , Sang-Hyuk Lee  7 , Seung Jae Lee  8 , Seung-Hwan Lee  9 , Myung Hun Jung  10 , Sang Woo Hahn  11 , Young-Chul Chung  12   13
Affiliations

Efficacy and Tolerability of Paliperidone Extended-release in the Treatment of First-episode Psychosis: An Eight-week, Open-label, Multicenter Trial

Nam-In Kang et al. Clin Psychopharmacol Neurosci. .

Abstract

Objective: We investigated the efficacy and tolerability of paliperidone extended-release (ER) tablets in patients with first-episode psychosis (n=75).

Methods: This was an 8-week, open-label, multicenter trial. The primary outcome variable was scores on the Positive and Negative Syndrome Scale (PANSS); secondary measures included the Scale for the Assessment of Negative Symptoms (SANS), the Cognitive Assessment Interview (CAI), and the Global Assessment of Functioning (GAF). To assess safety, we measured drug-related adverse events, weight, lipid-related variables, and prolactin and administered the Simpson-Angus Rating Scale (SARS), the Abnormal Involuntary Movement Scale (AIMS), the Barnes Akathisia Scale (BAS), the Arizona Sexual Experiences Scale (ASEX), and the Udvalg for Kliniske Undersogelser side effect rating scale (UKU).

Results: The administration of paliperidone ER resulted in significant improvement in the PANSS, SANS, CAI, and GAF scores (p＜0.001) over time. This improvement was evident as early as 1 week. The most frequent adverse events were akathisia, somnolence, anxiety, and sedation, which were well tolerated. Modest increases in weight and lipid profiles were also noted. Prolactin levels were substantially increased at the endpoint in both male and female patients.

Conclusion: These results indicate that paliperidone ER is effective and is characterized by good tolerability in the treatment of positive and negative symptoms and cognitive functioning in first-episode psychosis.

Keywords: Efficacy; First-episode psychosis; Paliperidone extended-release; Tolerability.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
CONSORT flow of participants through the trial.
See this image and copyright information in PMC

References

    1. Lieberman J, Jody D, Geisler S, Alvir J, Loebel A, Szymanski S, et al. Time course and biologic correlates of treatment response in first-episode schizophrenia. Arch Gen Psychiatry. 1993;50:369–376. doi: 10.1001/archpsyc.1993.01820170047006. - DOI - PubMed
    1. Robinson DG, Woerner MG, Alvir JM, Geisler S, Koreen A, Sheitman B, et al. Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry. 1999;156:544–549. - PubMed
    1. McEvoy JP, Lieberman JA, Perkins DO, Hamer RM, Gu H, Lazarus A, et al. Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison. Am J Psychiatry. 2007;164:1050–1060. doi: 10.1176/ajp.2007.164.7.1050. - DOI - PubMed
    1. Walter G, Wiltshire C, Anderson J, Storm V. The pharmacologic treatment of the early phase of first-episode psychosis in youths. Can J Psychiatry. 2001;46:803–809. - PubMed
    1. Opjordsmoen S, Melle I, Friis S, Haahr U, Johannessen JO, Larsen TK, et al. Stability of medication in early psychosis: a comparison between second-generation and low-dose first-generation antipsychotics. Early Interv Psychiatry. 2009;3:58–65. doi: 10.1111/j.1751-7893.2008.00103.x. - DOI - PubMed